Clinical Trial Update: Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating zoledronate versus observation for maintaining bone mineral density in patients undergoing surgery to remove both ovaries.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Breast and Ovarian Cancer Syndrome
• Osteoporosis
• Ovarian Carcinoma

Drugs mentioned

• Zoledronate (zoledronic acid)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Hereditary Breast and Ovarian Cancer Syndrome, Osteoporosis | Phase 2 | Status: COMPLETED | Results posted: 2020-03-24